Conference · Washington, District of Columbia
Pharmacovigilence and Risk Management Strategies USA 2013
Health · Pharmaceuticals · Biotechnology
Key numbers
- Editions on record
- 6first in 2012
About Pharmacovigilence and Risk Management Strategies Meeting
This global three-day program will provide new insights into the current issues and associated challenges impacting drug safety, focusing primarily on drug products and biologics, throughout all phases of development and marketed use. Top pharmaceutical, biotech and regulatory representatives who are experts in their field will discuss new and updated legislation in various ICH regions, current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global benefit-risk analyses and risk management plans, the impact of social media, and the role of epidemiology in safety analysis.
Featured Topics
Global regulatory updates
New EU regulations
Periodic benefit-risk evaluation reports
Benefit-risk analysis
Use of existing automated databases
Epidemiology
Social media
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2018 | 22–24 Jan 2018 | Omni Shoreham Hotel Washington, District of Columbia | — | — |
| 2017 | 23–25 Jan 2017 | Mandarin Oriental Washington DC Washington, District of Columbia | — | — |
| 2015 | 26–28 Jan 2015 | Renaissance Washington D C Hotel Downtown Washington, District of Columbia | — | — |
| 2014 | 13–15 Jan 2014 | Renaissance Washington D C Hotel Downtown Washington, District of Columbia | — | — |
| 2013 | 14–16 Jan 2013 | Renaissance Washington D C Hotel Downtown Washington, District of Columbia | — | — |
| 2012 | 23–25 Jan 2012 | Sheraton National Hotel Arlington, Virginia | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.